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Abstract 
We show that sequence and growth temperature effects on IB formation in the small, monomeric B-barrel protein interleukin-lp (IL-lb) can be 
quantitatively reproduced in an in vitro system in which IL-l/l is refolded from denaturant at different temperatures. The results suggest that 
temperature and mutational effects on IB formation may be based on intrinsic properties of the protein sequence rather than interactions with 
chaperones or other cellular factors. We also report striking correlations of IB formation with mutation-dependent changes in residue hydrophobicity. 
The nature of these trends differs considerably with residue position, however, suggesting that they are mediated by particular local environments 
created by an ordered structure. 
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1. Introduction 
High-level expression of foreign DNA in E. coli is 
often characterized by deposition of the protein product 
into electron-dense structures called inclusion bodies 
(IBs) [14]. Although of appreciable interest - as an as- 
pect of protein folding in the cell [5], as a practical barrier 
to recombinant expression [ 1,2], and as a kindred process 
to amyloid formation in human disease [4,5] - inclusion 
body formation is little understood. Recently we de- 
scribed a series of point mutants in the small, monomeric 
B-barrel protein interleukin-lb (IL-1B) which exhibit 
wide variation in the extent to which they are deposited 
into IBs when expressed in E. coli [6]. 
Of the mutants previously characterized, the 
Lys + Val mutation at position 97 (K97V), on a long, 
surface-exposed loop [7-lo], is of particular interest. Al- 
though exhibiting higher thermodynamic stability than 
wild-type IL- l/3, a much larger percentage of total IL- 18 
(K97V) is deposited into IBs than is the wild-type mole- 
cule [6]. Like a number of other IB-forming proteins 
[4,11], the proportion of the K97V mutant deposited into 
IBs significantly decreases when growth temperature is 
decreased [6]. We report here excellent correspondence 
between these temperature effects on IB formation by 
sequence variants and the temperature effects on aggre- 
gation in vitro when the same proteins are refolded from 
denaturant. The results suggest that these IB effects de- 
rive from the influence of amino acid replacements on 
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the kinetic partitioning of IL-l/3, as it folds, into soluble 
and insoluble products, rather than on any impact of the 
replacements on thermodynamic stability or on interac- 
tion interfaces with other cellular components during 
biosynthesis. 
2. Experimental 
2.1. Aggregation studies 
Both WT and the K97V of IL-lb were purified from the supernatant 
of a native lysate of E. coli as described previously [6]. For refolding 
studies. proteins were exhaustively dialyzed against distilled water and 
lyophilized. The lyophilized powder was dissolved in a small volume of 
3 M Gdn-HCl, IO mM MES, I mM EDTA, I mM DTT, pH 6.5, to 
give a protein concentration of 10 mg/ml. Although no particulates 
were apparent, the solution was centrifuged in an Eppendorf microfuge 
to insure the absence of large aggregates. Aliquots of this solution were 
pipetted, with mixing, into 9 ~01s. of buffer (10 mM MES, 1 mM 
EDTA, 1 mM DTT, pH 6.5) equilibrated at different temperatures. 
After 5 min, the reaction was removed from the thermal bath and 
allowed to stand another 5 min at RT. Insoluble aggregate was assessed 
by the turbidity of the sample [11,12], by reading the apparent absorb- 
ence of the refolding reaction at 480 nm in a spectrophotometer. As a 
control, folded K97V IL-lb exposed to the endpoint buffer concentra- 
tions (including 0.3 M Gdn-HCI) at 42°C generates no turbidity. 
The apparent plateau in aggregation at 48&54”C corresponds to 
aggregation of 91% of the available protein, as determined by a protein 
concentration assay (Biorad) on filtered samples after refolding at 48 
and 24°C. 
Concentration studies (Fig. 2) were performed by mixing the 3 M 
Gdn-HCl stock of the K97V mutant with either denaturation buffer 
alone or with the 3 M Gdn- HCI stock of WT IL-IS, before refolding 
at 48°C under conditions described above. 
2.2. Folding and unfolding kinetics 
Samples were folded/unfolded at 25’C in buffers containing IO mM 
MES, 90 mM NaCI, 1 mM /3-mercaptoethanol, pH 6.5. For refolding 
experiments, the stock protein solution was unfolded in 2 M Gdn-HCl 
overnight (16-24 h). Unfolding and refolding experiments were initi- 
ated by dilution of either folded or unfolded stock solutions into appro- 
priate Gdn-HCl buffer mixes to give the desired final Gdn-HCl concen- 
tration after manual mixing. The final protein concentration was O.I- 
0.3 mg/ml. The kinetics were monitored by fluorescence on an 
All rights reserved. 
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Fig. 1. Temperature dependence of aggregation during refolding of 
IL-l/I [WT (o), K97V (o)]. An Adso of 0.165 corresponds to 100% 
aggregation of available IL-IS (see section 2). Based on this determina- 
tlon, A,,, values of 0.100 (42°C) and 0.031 (32°C) correspond to aggre- 
gation of 61% and 19% of total available IL-lb, and these values are 
reported in Table 1. 
SLM-8000 spectrofluorometer with excitation set at 295 nm (slit 1 mm) 
and emission at 343 nm (slit 4 mm). Data were fit to a sum of exponen- 
tials using the program NLIN (SAS, Gary, NC). The data fit best to 
a single exponential as determined by random deviation of the sum of 
the squares of the residuals. The aggregation and light scattering effects 
discussed in this paper did not interfere with these kinetic measurements 
since, as shown in Fig. 1, both wild-type and K97V IL-ID fold to soluble 
products at 25°C. 
3. Results and discussion 
Previously we reported that all of the IL-lp sequence 
variants tested are stable to thermally induced aggrega- 
tion in vitro at temperatures greater than 5O”C, yet at the 
same time support IB formation in vivo at temperatures 
as low as 32°C. We interpreted this data to suggest hat 
differences in the thermodynamic stability of the native 
state cannot account for mutational effects on IB forma- 
tion in this series of mutants [6]. Other ways in which 
mutational and thermal effects might be mediated are: 
(a) effects on the solubility or kinetic lifetime of a tran- 
sient folding intermediate; or (b) effects on a chaperone 
interaction or some other component of the biosynthetic 
machinery. Here we compare the K97V mutant and the 
WT in an in vitro system designed to explore the behav- 
ior and solubility of the polypeptide during folding. 
Fig. 1 shows that the wild-type protein can be refolded 
to a soluble product throughout the temperature range 
24- 54°C. Although the K97V mutant also folds effi- 
ciently and remains soluble at 24”C, it generates appre- 
ciable aggregate when refolded at 32”C, and the amount 
of aggregate increases linearly with temperature up to 
about 50°C. The aggregation seen at 50°C represents 
loss of about 90% of the total IL-IS from solution (see 
section 2). It should be emphasized that these tempera- 
ture effects require that IL-l/? be actively engaged in the 
Table 1 
% aggregation of IL-ID in vivo and in vitro 
In vivo” In vitrob 
IL-liz 32°C 42°C 32°C 42°C 
WT 6 S-18 0 0 
K97V 17 47-61 19 61 
“Determined from SDS-PAGE on native lysis supernatants and pellets, 
developed by Coomassie blue staining and/or by immunoblots with an 
anti-IL-I/3 antibody (from [6]). 
bData from Fig. I. 
folding process; as we have shown previously, thermally 
induced aggregation of folded IL- l/3 requires higher tem- 
peratures and also displays a much sharper temperature 
dependence [13]. The aggregation of the K97V mutant 
during folding in vitro is concentration dependent, as 
expected for a rate-limiting multi-molecular eaction step 
(data not shown). 
Table 1 compares the aggregation in this in vitro ex- 
periment with the temperature dependent inclusion body 
formation of these sequence variants [6]. The table shows 
a remarkably good agreement between the in vivo and 
in vitro aggregation results. This suggests that - at least 
for IL-l/? sequence variants - thermal effects on IB 
formation do not depend on the temperature dependence 
of ribosomal synthesis rates, and mutational effects are 
not due to disruption of an interaction surface with a 
molecular chaperone. 
Since aggregation of IL-lp during folding in vitro can 
account for several properties of IB formation, while the 
thermal aggregation of folded IL-l/? cannot [6], we con- 
clude that formation of IL-l/I inclusion bodies depends 
on the properties of a folding intermediate. Independent 
evidence also supports the involvement of a folding inter- 
mediate in aggregation of IL-la in vitro [13] and in vivo 
[13,14]. There are two broad mechanisms by which mu- 
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Fig. 2. Kinetics of folding/unfolding of WT (0) and K97V (m) IL-Ip. 
See section 2. Data points between 0 and 1.5 M Gdn-HCI are from 
refolding experiments while data above 1.5 M Gdn-HCI were from 
unfolding experiments. 
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tations might impact aggregation of folding intermedi- 
ates [4]: (a) by increasing the intrinsic tendency of a key 
folding intermediate to aggregate; or (b) by increasing 
the kinetic lifetime - and thus increasing the steady state 
concentration - of an aggregation-prone intermediate. 
Although it is sometimes possible to determine the 
solubility properties of a folding intermediate populated 
at equilibrium [ 15,161, it is much more difficult to charac- 
terize solubilities or other physical properties of transient 
folding intermediates. We therefore explored the second 
possibility, that the K97V mutation affects the kinetic 
lifetime of an important intermediate. We determined the 
folding kinetics of both WT and K97V at 25°C and low 
protein concentration, conditions which allow folding of 
both proteins to proceed with good solubility. However, 
for the kinetic phase accessible using manual mixing 
techniques, we observed no difference in the refolding (as 
well as unfolding) rates of WT and K97V (Fig. 2). This 
does not rule out an effect on kinetic lifetime of an inter- 
mediate, however, since IL-l/? is known to exhibit at 
least five steps in its folding, with kinetic half-lives for the 
reaction from 4 ms to 20 min at 4°C [17]. Comparison 
of the two proteins by rapid kinetics techniques will be 
required to further explore potential differences in fold- 
ing rates’. 
Analysis of extents of IB formation with respect to 
sequence position suggests that the folding intermediate 
implicated in the aggregation process has significant 
structure. Fig. 3 shows that, for a collection of replace- 
ments at eight different sequence positions in IL-lp, 
there is no overall correlation of the extent of IB forma- 
tion with the change in hydrophobic character brought 
about by the replacement, as quantified by changes in 
free energies of transfer [18,19]. This suggests that the 
aggregating species must possess enough structure to 
create different environments which exhibit unequal re- 
sponses to similar hydrophobicity changes. In fact, quite 
different IB extents are associated with identical replace- 
ments at different residue positions in IL-l/3’. These 
results are inconsistent with any model in which the ag- 
gregating species is a random coil in which sequence 
positions are equivalent. 
Despite the absence of a universal trend, strong corre- 
lations are obtained between IB% and UG,,,,, at indi- 
vidual sequence positions in IL-l/?, as shown in Fig. 3. 
At position 9 (located in the interior of folded IL-l/I) 
‘It is not clear whether all the intermediates detected at 4°C would be 
detectable at 25°C; however, the fact that much of the signal amplitude 
for folding of IL-l/3 is not detectable in our manual mixing experiments 
(B.A. Chrunyk and R. Wetzel, unpublished observations) suggests that 
one or more relatively rapid kinetic phases proceed the step we have 
been able to measure at 25°C. Since the generation of light scattering 
aggregate at 42°C is at least as rapid as the folding step shown in Fig. 
2 (B.A. Chrunyk and R. Wetzel, unpublished observations), it is possi- 
ble that the intermediate responsible for aggregation is populated ear- 
lier in the folding pathway. 
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Fig. 3. Correlation of extent of inclusion body formation with the 
difference in free energies of transfer [l&19] between wild-type and 
single point mutant ILlg molecules for all mutants quantified. (The 
inclusion body data for replacements of Arg4, Se?, Leu6, Asn’, Thr’, 
Leu”‘, Glt? and Ly? can be found in [6].) MC?,,,,, was generated by 
subtracting the free energy of transfer [l&19] of the WT residue from 
that of the mutant residue. (0, position 97 mutants; l , position 9 
mutants; A, other mutants. 
increasing IB formation correlates with decreasing hy- 
drophobicity. In contrast, at position 97 (on the surface 
of the folded protein), increasing IB formation correlates 
with increasing hydrophobicity. The former effect might 
be compatible with the environment of position 9 in the 
native state, since placing a hydrophilic group in a hy- 
drophobic pocket would be expected to be destabilizing. 
The latter effect, however, is incompatible with the envi- 
ronment of position 97 in the native structure: in general, 
replacement of surface residues is not normally found to 
greatly effect stability [20], and, in this case, the 
Lys + Val mutation at position 97 is known to be stabi- 
lizing to the native state [6]! Thus, the aggregating species 
in IB formation has both native-like and non-native envi- 
ronments by this analysis. Other data supports the role 
of a structured intermediate in IB formation by IL-l,&. 
Recent FTIR studies indicate that the secondary struc- 
ture of IL-1B in inclusion bodies - as well as in in vitro 
aggregates - is similar to, but clearly not identical with, 
that of the native IL-1B structure [14]. In addition, an 
aggregation-prone, native-like unfolding intermediate 
*For example, three Lys-+Gly replacements have been characterized in 
IL-IS. At position 94, wild-type levels of soluble protein expression are 
obtained; however, the same mutation at position 88 gives loss of stable 
expression (either in IBs or in the soluble fraction), and at position 97 
gives an enhanced level of IB formation over that seen for the WT. At 
position 6, a Leu+Ala replacement leads to a slight enhancement of 
IB formation over WT, the same replacement at position 10, on the 
same face of the same /?-strand, gives IB formation almost exclusively. 
The Thr+Ala mutation at position 9 gives no significant different in 
expression level or IB formation from WT, but the same replacement 
at position 79 gives little soluble expression and enhanced IB formation. 
See [6]. 
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has been suggested based on the behavior of the K9lV 
mutant in its unfolding-dependent aggregation in vitro 
1131. 
Properties of folding intermediates have been invoked 
to account for the temperature-sensitive folding muta- 
tions, manifested by differences in extents of in vivo 
aggregation, described for the large, homotrimeric tail- 
spike protein of phage P22 [3,21]. Recent in vitro folding 
studies support this interpretation [22,23]. The results 
presented here suggest that mutational effects on the 
kinetic lifetime or solubility of a folding intermediate can 
also account for effects on IB formation by the small, 
globular, monomeric protein IL-l/?, and the availability 
of structural information has contributed to our under- 
standing of these effects. The quantitative duplication of 
thermal and mutational effects on IB formation in the in 
vitro model suggests that measured extents of IB forma- 
tion, at least in this case, reflect a property inherent to 
the structure of the polypeptide chain and the folding 
intermediates governed by that sequence, and are not the 
result of effects on chaperone binding sites, ribosomal 
synthesis rates, proteolysis rates, etc. 
As an intrinsic aspect of polypeptide structure, the 
tendency to aggregate during folding can be viewed as 
a design flaw which has haunted organic evolution [5]. 
It is likely that aggregation during folding has provided 
a continuing, selective pressure on protein sequence evo- 
lution which operates in addition to a more generally 
recognized selection for net folding stability [5]. For at 
least some sequences which have proved incapable of 
avoiding aggregation, biosynthetic pathways appear to 
have been embellished to suppress aggregation during 
folding in vivo, for example through the use of molecular 
chaperones [24]. 
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